Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,649 | -1,164 | -254 | -1,957 | -1,416 |
| Depreciation Amortization | 10 | 1 | 10 | 36 | 26 |
| Accounts receivable | 117 | 686 | 1,068 | 5,617 | 5,668 |
| Other Working Capital | -145 | 961 | 2,216 | 4,156 | 4,853 |
| Other Operating Activity | 1,594 | 636 | -293 | -4,127 | -4,467 |
| Operating Cash Flow | $-73 | $1,119 | $2,746 | $3,725 | $4,663 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -812 | N/A | N/A | -3,649 | -4,123 |
| Investing Cash Flow | $-812 | $0 | $0 | $-3,649 | $-4,123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 653 | 653 | 37 | 380 | 233 |
| Common Stock Repurchased | -419 | -419 | N/A | N/A | 0 |
| Financing Cash Flow | $235 | $235 | $37 | $380 | $233 |
| Beginning Cash Position | 3,950 | 3,950 | 3,950 | 3,494 | 3,494 |
| End Cash Position | 3,300 | 5,304 | 6,734 | 3,950 | 4,268 |
| Net Cash Flow | $-651 | $1,354 | $2,783 | $456 | $773 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73 | 1,119 | 2,746 | 3,725 | 4,663 |
| Free Cash Flow | -73 | 1,119 | 2,746 | 3,725 | 4,663 |